TPO and COVID-19: A study involving 124 hospitalized COVID-19 patients reported that 94.4% of survivors were euthyroid 6 months after hospital discharge, whereas, in certain patients, the period following recovery was linked to notably higher anti-TPO titers and the emergence or persistence of subclinical hypothyroidism (55).